Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
Clinical trial NCT03248479 · TERMINATED
Trial details
- NCT number
- NCT03248479
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2023-09-05
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.